Paul Evangelista Paid for 9 Shares of Century Bancorp, Inc. (CNBKA); Fate Therapeutics (FATE) Shorts Increased By 73.78%

May 19, 2017 - By Marguerite Chambers

Fate Therapeutics Incorporated (NASDAQ:FATE) had an increase of 73.78% in short interest. FATE’s SI was 560,600 shares in May as released by FINRA. Its up 73.78% from 322,600 shares previously. With 208,800 avg volume, 3 days are for Fate Therapeutics Incorporated (NASDAQ:FATE)’s short sellers to cover FATE’s short positions. The SI to Fate Therapeutics Incorporated’s float is 2.34%. About 215,265 shares traded. Fate Therapeutics Inc (NASDAQ:FATE) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Paul Evangelista, Executive Vice President of Century Bancorp Inc, in an insider buying trade paid for 9 shares whose amount is estimated to be $564 at average stock price of $62.7. In the last 30 days, he also bought 7 shares that are worth approx $620 USD. Paul Evangelista now holds 1,952 shares of the Firm. The dated May 19, 2017 transaction’s filing filed with the DC-based SEC is ready for use here.

Investors sentiment increased to 1.15 in 2016 Q4. Its up 0.06, from 1.09 in 2016Q3. It increased, as 2 investors sold Century Bancorp, Inc. shares while 25 reduced holdings. 11 funds opened positions while 20 raised stakes. 1.89 million shares or 1.75% more from 1.86 million shares in 2016Q3 were reported. New York State Common Retirement Fund stated it has 0% of its portfolio in Century Bancorp, Inc. (NASDAQ:CNBKA). 56,154 are owned by State Street Corp. Commonwealth Equity Services Incorporated invested in 4,510 shares or 0% of the stock. Maltese Capital Mgmt Limited Liability Company holds 1.52% in Century Bancorp, Inc. (NASDAQ:CNBKA) or 281,040 shares. First Manhattan holds 6,300 shares. Blackrock holds 0% or 338 shares in its portfolio. Lsv Asset owns 38,477 shares for 0% of their portfolio. Clean Yield Gru invested in 2.96% or 109,368 shares. Blackrock Institutional Tru Na holds 0% of its portfolio in Century Bancorp, Inc. (NASDAQ:CNBKA) for 31,714 shares. First Quadrant L P Ca reported 890 shares stake. Rhumbline Advisers reported 4,273 shares. Northern Trust accumulated 44,235 shares. Jacobs Asset Mgmt Ltd holds 145,000 shares. 32,804 are held by Bancshares Of Ny Mellon. Vanguard Group holds 0% or 113,068 shares in its portfolio.

The stock increased 0.51% or $0.3 during the last trading session, reaching $59.55. About 3,726 shares traded. Century Bancorp, Inc. (NASDAQ:CNBKA) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Analysts await Century Bancorp, Inc. (NASDAQ:CNBKA) to report earnings on July, 11.

Since November 21, 2016, it had 61 insider purchases, and 0 insider sales for $1.12 million activity. Another trade for 46 shares valued at $4,556 was made by SLOANE BARRY R on Tuesday, January 17. Another trade for 34 shares valued at $2,078 was bought by Filler James J. On Tuesday, February 21 the insider Kay Linda Sloane bought $1,251. Another trade for 3 shares valued at $187 was made by Feeney Brian J. on Friday, February 17. $125 worth of Century Bancorp, Inc. (NASDAQ:CNBKA) shares were bought by Delinsky Stephen R. EVANGELISTA PAUL A also bought $104 worth of Century Bancorp, Inc. (NASDAQ:CNBKA) on Monday, December 19. WESTLING JON also bought $7,007 worth of Century Bancorp, Inc. (NASDAQ:CNBKA) on Wednesday, February 15.

Century Bancorp, Inc. is a state-chartered bank holding company. The company has market cap of $297.29 million. The Firm has a banking subsidiary: Century Bank and Trust Company . It has a 17.72 P/E ratio. The Firm offers a range of services to commercial enterprises, state and local Governments and agencies, non-profit organizations and individuals.

Investors sentiment decreased to 0.73 in 2016 Q4. Its down 0.09, from 0.82 in 2016Q3. It turned negative, as 6 investors sold Fate Therapeutics Inc shares while 9 reduced holdings. 2 funds opened positions while 9 raised stakes. 22.91 million shares or 18.48% more from 19.34 million shares in 2016Q3 were reported. Da Davidson reported 720 shares. Redmile Group Ltd holds 0.31% of its portfolio in Fate Therapeutics Inc (NASDAQ:FATE) for 1.42 million shares. Franklin Res Incorporated has 6.08 million shares for 0.01% of their portfolio. Jacobs Levy Equity stated it has 93,982 shares. State Bank Of Ny Mellon owns 0% invested in Fate Therapeutics Inc (NASDAQ:FATE) for 58,558 shares. Vanguard Group reported 631,995 shares. 4,030 are held by Blackrock Advisors Lc. Creative Planning has invested 0% of its portfolio in Fate Therapeutics Inc (NASDAQ:FATE). Panagora Asset Mgmt holds 0% in Fate Therapeutics Inc (NASDAQ:FATE) or 29,510 shares. 209,900 were accumulated by Renaissance Tech Limited Liability. Northern Tru Corporation owns 39,773 shares for 0% of their portfolio. Goldman Sachs Gp reported 0% stake. 4,596 were reported by Blackrock Mgmt Llc. Wells Fargo & Mn owns 27,379 shares. Blackrock Institutional Trust Company Na owns 5,728 shares.

Since November 23, 2016, it had 3 insider buys, and 0 sales for $1.25 million activity. Coughlin Timothy P had bought 56,390 shares worth $149,997 on Wednesday, November 23. $999,998 worth of stock was bought by RASTETTER WILLIAM H on Wednesday, November 23. Shares for $99,997 were bought by Storgard Chris.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: